Mon, Mar 2, 2015, 6:56 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Nokia Corporation Message Board

pileofspuds 3 posts  |  Last Activity: Jan 27, 2015 6:28 AM Member since: Apr 29, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • pileofspuds by pileofspuds Jan 27, 2015 6:28 AM Flag

    Unbelievable that the market payed any attention to the Brean article yesterday, that was nothing more than an emotional filled "sour grapes" article that has no basis in reality.

    Why would anybody take Ashcroft's opinion over those who have much more objective and knowledgeable

    Like the world's leading nephrologists, who voted Rockwell's Triferic abstract best in class back in Feb 2014.
    Or Baxter, who made a sizable long term financial investment with Rockwell.
    Or FDA and AdCom panel of experts, whose job it is to objectively and intimately decide on effectiveness of a drug, and who overwhelmingly gave Triferic a thumbs up.
    Or Chardan, Summer St, and Oppenheimer analysts, who at least write reports that don't contain subjective phrases such as "skid and crash".
    Or patients who received Triferic during the trials, who felt 100% better after receiving Triferic versus standard IV iron.

    Don't think that Rockwell has been idle these past 6 months, there are many deals lined up with all the major dialysis centers. DaVita will be first, given it's relationship with Rockwell, and the campaign will be a major rollout. Other centers will deploy in a more subdued fashion, but expectation will ramp up soon once the financial benefits are seen as well as the clamoring from patients to be on the drug.

    Expect these announcements within weeks, as well as plans as for global rollout into Europe.

    Rockwell will be successful, there is no doubt. See you at $30+ by the end of the year.

    Sentiment: Strong Buy

  • pileofspuds pileofspuds Jan 24, 2015 1:01 PM Flag

    I am sure Rockwell has the decision from FDA and they chose to wait til Monday open before releasing.

    I almost think that if it was negative, it would be better to release sooner rather than later, give investors time to chew on it for a day or two before panic selling. Still go down, but maybe not as much as it could.

    And, if it was positive, just the opposite. Release just before market open, to induce panic buying and higher price increase. Also doesn't give the short blabbermouths (Feinstein, Ashcroft) time to write a negative article as to why the approval is not that big of a deal.

    We'll find out, but feeling good Otis!!

  • pileofspuds by pileofspuds Dec 16, 2014 5:40 PM Flag

    Wow, looks like he is all in! If I did my math correctly, not only does he have the 2.1 million direct shares, he also has an additional 6.3 million shares through the preferred options!

8.08+0.07(+0.87%)Mar 2 4:03 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.